Scott Biller, Chief Scientific Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 3,000 shares at $84.10 ($249K) on 2018-03-05, disclosed to the SEC on 2018-03-07.
Open-market sale of $249k AGIO by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.93 | 400 | $32K | 13.0% |
| 2 | $82.04 | 400 | $33K | 13.2% |
| 3 | $83.21 | 1,100 | $92K | 36.7% |
| 4 | $84.10 | 1,100 | $93K | 37.1% |
| Total | $83.08 avg | 3,000 | $249K | 100% |
| Filing → |
| AGIO | SELL | 2019-03-01 | $585K | — | Filing → |
| AGIO | SELL | 2018-11-07 | $209K | — | Filing → |
| AGIO | SELL | 2018-10-09 | $277K | — | Filing → |